Skip to content
Clinical Trials – home

Obesity Diagnostics

59 / 116 trials open to patients24 countries1 support organisation

In short

Diagnosing obesity involves more than just stepping on a scale. Healthcare providers use several methods to assess body weight, measure fat distribution, and identify related health complications. Understanding when and how obesity is diagnosed can help you take control of your health and start a conversation with your doctor about the best path forward for your individual needs.

Key points

  • Obesity is a chronic medical condition, not just a cosmetic concern, and early diagnosis can prevent serious health complications.
  • BMI is the most common tool for screening obesity, but it has limitations and should be combined with other measurements like waist circumference.
  • Waist circumference is a powerful indicator of metabolic risk because it measures harmful abdominal fat.
  • Blood tests help identify obesity-related complications such as diabetes, high cholesterol, and liver disease, guiding treatment decisions.
  • Clinical trials for obesity require thorough diagnostic screening, including BMI, blood tests, and sometimes imaging studies, to ensure participant safety and study accuracy.
  • Children and adults with a family history of weight-related conditions should seek diagnostic evaluation even if they feel healthy.
  • Regular monitoring of weight, BMI, and waist circumference is recommended to track changes and intervene early if needed.

Introduction: Who Should Seek Diagnostic Evaluation for Obesity

If you notice that your weight has been increasing steadily over time, or if you struggle with clothes that no longer fit comfortably, it may be time to speak with a healthcare provider. Obesity is not simply about appearance—it is a chronic medical condition that can affect your overall health and quality of life. Anyone who feels their weight may be affecting their daily activities, energy levels, or emotional well-being should consider seeking a professional evaluation.

Certain groups of people should be particularly proactive about seeking diagnostic testing. Adults with a family history of weight-related conditions such as diabetes, heart disease, or high blood pressure should discuss their weight with a doctor, even if they do not yet feel unwell. Individuals who have experienced significant weight gain after starting certain medications—such as antidepressants, steroids, or diabetes medications—may also benefit from an evaluation to understand whether obesity has developed and what complications might be present.

It is also advisable to seek diagnostics if you have noticed symptoms that might be linked to obesity-related complications. For example, if you experience shortness of breath during light activities, persistent fatigue, joint pain, sleep disturbances, or symptoms of depression and anxiety, these could be signs that obesity is affecting your body systems. Even modest weight gain around the abdomen may increase your risk for metabolic problems, so early evaluation can prevent more serious issues down the line.

Children and adolescents are not immune to obesity, and parents should be attentive to changes in their child's growth patterns. If a child is significantly heavier than peers of the same age and height, or if there are concerns about eating habits, physical activity levels, or emotional health, a pediatric evaluation is important. Obesity in childhood is associated with a wide range of serious health complications and an increased risk of remaining obese into adulthood.

Diagnostic Methods Used to Identify and Classify Obesity

When you visit a healthcare provider to discuss concerns about your weight, the first step is usually a comprehensive health history review. Your provider will ask about your weight history, including when you first noticed weight gain, any previous attempts to lose weight, and how successful those efforts were. They will also inquire about your eating patterns, physical activity levels, sleep quality, stress levels, and any medications you take that might contribute to weight gain. This conversation helps the provider understand the factors that may have contributed to your current weight status.

A physical examination follows the health history. During this exam, your provider will measure your height and weight to calculate your Body Mass Index (BMI), which is a number derived from your weight in kilograms divided by your height in meters squared. BMI is the most commonly used tool to screen for obesity in adults. A BMI of 30 or higher is generally classified as obesity, while a BMI between 25 and 29.9 indicates overweight status.

Healthcare providers further classify obesity into three main classes based on BMI. Class I obesity corresponds to a BMI between 30 and less than 35. Class II obesity is defined as a BMI between 35 and less than 40. Class III obesity, sometimes referred to as severe obesity, is indicated by a BMI of 40 or higher. These classifications help doctors assess the level of health risk and determine the intensity of treatment that may be needed.

While BMI is a useful screening tool, it does have limitations. BMI does not directly measure body fat, nor does it distinguish between fat mass, muscle mass, and bone mass. This means that some individuals, such as athletes with high muscle mass, may have a high BMI without having excess body fat. Conversely, older adults or others who have lost muscle may have a normal BMI but still carry unhealthy amounts of fat. For this reason, healthcare providers often use additional measurements to get a more complete picture.

One important additional measurement is waist circumference, which helps identify where fat is distributed on the body. Excess fat stored around the abdomen, also known as visceral fat, is particularly harmful because it increases the risk of heart disease, type 2 diabetes, and other metabolic problems. In women, a waist circumference greater than 35 inches and in men, greater than 40 inches, suggests a higher risk for obesity-related complications. Measuring waist circumference is simple and provides valuable information that BMI alone cannot offer.

Your provider may also check your vital signs, including blood pressure, heart rate, and temperature. High blood pressure is a common complication of obesity and can be detected during a routine physical exam. Listening to your heart and lungs can reveal signs of strain or dysfunction related to excess weight.

In some cases, healthcare providers may order blood tests to assess metabolic health and identify complications. These tests can measure blood sugar levels to detect diabetes or prediabetes, check cholesterol and triglyceride levels to evaluate heart disease risk, and assess liver and kidney function. Blood tests are not used to diagnose obesity itself, but they help identify the presence of related conditions that require treatment.

For individuals with suspected complications such as sleep apnea, additional diagnostic tests may be necessary. Sleep apnea is a condition where breathing repeatedly stops and starts during sleep, and it is more common in people with obesity. If your provider suspects sleep apnea, they may refer you for a sleep study, which monitors your breathing, oxygen levels, and sleep patterns overnight.

Imaging tests such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) may be used to assess obesity-related complications affecting specific organs. For example, an abdominal ultrasound can help diagnose fatty liver disease, a condition where excess fat accumulates in the liver and can lead to inflammation and damage. These imaging tests are not routine for everyone with obesity but are important when specific complications are suspected.

Diagnostics for Clinical Trial Qualification

Clinical trials that test new treatments for obesity often have specific criteria that participants must meet before they can enroll. These criteria help researchers ensure that the study results are reliable and that participants are appropriate candidates for the treatment being tested. If you are considering joining a clinical trial for obesity, you will undergo a thorough diagnostic evaluation to determine whether you qualify.

The first and most common requirement is a BMI measurement within a specific range. Many obesity clinical trials require participants to have a BMI of 30 or higher, which is the standard threshold for obesity. Some trials may focus on individuals with more severe obesity, requiring a BMI of 35 or 40 or higher. Trials testing treatments for people who are overweight but not yet obese may set a lower BMI threshold, such as 27 or higher, particularly if the participant has at least one weight-related health condition like high blood pressure or prediabetes.

In addition to BMI, clinical trials often require documentation of obesity-related complications. This means you will need blood tests to measure your blood sugar, cholesterol, triglycerides, and liver function. These tests help researchers understand the metabolic effects of obesity and track how the treatment affects these markers over time. If you have conditions such as type 2 diabetes, high blood pressure, or fatty liver disease, these diagnoses may make you eligible for certain trials that are specifically studying treatments for people with those complications.

Waist circumference measurement is also commonly included in trial screening protocols, especially for studies focused on metabolic health. Researchers use waist circumference to assess abdominal fat distribution, which is a key risk factor for cardiovascular and metabolic complications.

Some trials may require imaging studies to assess the degree of fat accumulation in specific organs. For example, trials investigating treatments for fatty liver disease may require an abdominal ultrasound, MRI, or specialized test to measure liver fat content before enrollment. Imaging can also be used to measure visceral fat, which is the fat stored deep in the abdomen around the organs.

A detailed medical history review is a standard part of trial screening. You will be asked about your weight history, previous weight-loss efforts, current medications, and any existing health conditions. Some trials exclude individuals who have recently undergone weight-loss surgery or who are taking certain medications that affect weight. Others may specifically seek participants with particular health backgrounds to study how treatments work in different populations.

Physical activity levels and dietary habits may also be assessed during screening. Some trials require participants to maintain stable eating and exercise patterns during the study, while others may include lifestyle intervention as part of the treatment being tested. Understanding your baseline habits helps researchers measure the effects of the treatment accurately.

Mental health screening is increasingly recognized as an important part of clinical trial diagnostics for obesity. Researchers may use questionnaires or interviews to assess symptoms of depression, anxiety, or eating disorders, as these conditions can influence weight and response to treatment. Some trials may exclude individuals with certain mental health conditions, while others may be designed specifically to study how treatments affect both weight and mental well-being.

Pregnancy tests are often required for women of childbearing age before they can enroll in obesity clinical trials. Many experimental treatments have not been studied in pregnant women and could pose risks to a developing fetus. Women who are pregnant, planning to become pregnant, or breastfeeding are typically excluded from obesity treatment trials.

Throughout the trial, participants undergo regular diagnostic monitoring to track progress and detect any side effects. This typically includes repeat measurements of weight, BMI, waist circumference, blood pressure, and laboratory tests at scheduled intervals. Imaging studies may be repeated to assess changes in fat distribution or organ health. This ongoing monitoring ensures participant safety and provides data on how well the treatment is working.

The diagnostic requirements for clinical trial qualification are thorough and can seem demanding, but they serve important purposes. They help ensure that the right people are enrolled, that the treatment is studied in a safe and scientifically valid way, and that the results will be meaningful for future patients. If you are interested in participating in an obesity clinical trial, discussing your health status and diagnostic test results with your healthcare provider is the first step toward determining whether you might be a good candidate.

Did you know?

  1. The BMI scale was originally developed in the 1830s by a Belgian mathematician, not a medical doctor, to study population trends—not to diagnose individuals.
  2. Waist circumference can be a better predictor of heart disease risk than BMI because it specifically measures abdominal fat, which is more metabolically harmful than fat in other areas.
  3. Some clinical trials now use advanced imaging techniques to measure the exact amount of visceral fat around organs, providing far more detail than a simple scale or tape measure ever could.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Obesity

Recruiting trials first

See all 116 trials →
Quick filters

116 clinical trials in this condition

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:0–17 years
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Tirzepatide
  • Sponsor:Klinikum rechts der Isar der TU Muenchen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
See all 116 trials →filters applied: condition = Obesity

Where to find support

Patient organisations offering help, community and advocacy

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).